GLP-1RAs are still comparatively new, and they have not previously been in use on this scale
In overweight/obese and/or diabetic patients, GLP-1RA therapy was not associated with an increased risk of psychiatric side effects or worsening of depressive symptoms compared with placebo and was associated with improved quality of life, control of food intake and emotional eating behavior
For example, in the acidic environment of the stomach, glutathione's chemical bonds may be broken, rendering it partially inactivated before it reaches the intestinal absorption site
It stimulates bowel movements by boosting certain digestive hormones and triggering contractions in the colon
Yu BZ, Kaimal R, Bai S, El Sayed KA, Tatulian SA, Apitz RJ, et al
B.WangC